Search

Dalian Xinhongrui New Materials Technology Co., Ltd., located in the Jinpu New Area of Dalian City, Liaoning Province, is a national high-tech enterprise specializing in the research, development, production, and sales of high-performance functional fillers, inorganic nanocomposites, and environmentally friendly modified auxiliaries. The company is currently at the mid-industrialization stage, having completed pilot-scale amplification and achieved stable batch supply. Its registered capital is RMB 10 million, fully paid-in, and it has 27 employees covered by social insurance.  

The company’s core business covers three major areas:  
(1) High-thermal-conductivity fillers—including spherical alumina, boron nitride, and silica powder—used in thermal interface materials for new-energy vehicle battery modules, heat-dissipation substrates for 5G base stations, and LED packaging;  
(2) Surface-controllably modified inorganic powders treated with coupling agents, enhancing mechanical properties and interfacial compatibility in engineering plastics, rubber, and adhesive systems;  
(3) Low-VOC eco-friendly auxiliaries for green building materials and waterborne coatings, including ultrafine hollow glass microspheres, modified mica, and bio-based dispersants/stabilizers.  

Its core technology relies on an integrated process combining “multi-stage gradient temperature-controlled pneumatic grinding” and “plasma surface activation,” enabling precise control of spherical alumina’s D50 at 15 ± 1.2 μm (CV ≤ 4.8%), thermal conductivity of 32.6 W/(m·K), and dielectric loss tangent < 0.0012 @ 1 MHz. The company has filed 14 invention patent applications (9 granted, including 1 U.S. patent), 8 utility model patents, and 2 software copyrights.  

It has obtained certifications for ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018; holds the “Level-3 Standardized Enterprise for Safety Production (Hazardous Chemicals)” certificate; and has issued an IATF 16949 automotive supply chain quality management system transitional compliance statement. Two of its flagship products have been included in the “2025 Liaoning Provincial Key New Materials First-Batch Application Demonstration Guidance Catalog.”  

The company supplies customized high-purity spherical alumina thermal conductive fillers to CATL’s Kirin battery modules, delivering 126 tons in 2025. In collaboration with Nippon Paint China, it developed mica modified specifically for waterborne metallic anticorrosive coatings, now incorporated into the supply chains of CIMC Vehicles and XCMG Group. It also undertakes the sub-project “Interfacial Regulation Mechanism of Highly Stable Nanofillers in Solid Electrolytes” under China’s National Key R&D Program.  

In 2025, its export value reached RMB 18.47 million, with shipments to South Korea (41%), Germany (29%), and Vietnam (17%). Customers include LG Chem, Henkel AG, and VinFast. All exported products have completed REACH registration and RoHS 2.0 compliance certification, and the company possesses authorization to use the CE marking.

Dalian Xinqiu Fine Chemical Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of fine chemicals, focusing on customized supply of high-value-added intermediates and process optimization services for pharmaceuticals, agrochemicals, and dyes. The company’s core business encompasses the development and manufacturing of organic intermediates, pharmaceutical intermediates, agrochemical intermediates, dye intermediates, and specialty chemicals. Its products are widely utilized within the supply chains of domestic pharmaceutical enterprises (e.g., Northeast Pharmaceutical Group, Yangtze River Pharmaceutical Group) and leading agrochemical companies (e.g., Zhejiang Xinan Chemical Industrial Group Co., Ltd., Jiangsu Yangnong Chemical Co., Ltd.), and are exported to India, South Korea, and Southeast Asian countries, with export business accounting for approximately 28% of total operations. The company possesses outstanding technological R&D capabilities, holding 12 invention patents and 9 utility model patents. Its core technologies focus on the synthesis of fluorinated aromatic compounds, control of metal-catalyzed coupling reactions, and crystallization purification of high-purity intermediates; notably, the “continuous preparation method for 2,4-dichlorofluorobenzene” has already been industrialized. The company has established a provincial-level enterprise technology center and has obtained certifications for ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, and ISO 45001:2018 Occupational Health and Safety Management System. It was recognized as a National High-Tech Enterprise in 2021 and was selected for Liaoning Province’s list of “Specialized, Sophisticated, Distinctive, and Innovative” small- and medium-sized enterprises in 2022. Leveraging industry-university-research collaboration with the State Key Laboratory of Fine Chemicals at Dalian University of Technology, the company continuously undertakes technological breakthroughs in areas such as green oxidation processes. Current primary cooperation models include customized intermediate development, process improvement services, and joint technological research and development, aiming to provide stable, efficient, and compliant fine chemical solutions across the industrial chain.

Dalian Xin’an Energy Co., Ltd. is registered in Ganjingzi District, Dalian City, Liaoning Province. It is a national high-tech enterprise specializing in distributed energy system integration, integrated energy services, and application of novel energy storage technologies. Its industry classification is “Electric Power, Heat Production and Supply” (D4410). Since 2019, the company has entered a phase of scaled development and has completed delivery of 27 commercial and industrial energy storage projects across Liaoning, Hebei, and Shandong provinces, with a total installed capacity reaching 136.8 MWh.  

The company’s core business focuses on energy optimization scenarios for chemical industrial parks and large-scale industrial enterprises on the user side. Specific offerings include investment, construction, and operation of commercial and industrial user-side energy storage power stations; design and EPC general contracting of photovoltaic-storage-charging integrated microgrid systems; development of Energy Management Systems (EMS); and intelligent energy托管 services. Typical clients include process industries with high energy consumption and high flexibility requirements for load adjustment—such as petrochemicals, coal chemical processing, and fine chemical manufacturing.  

Its core technical capabilities encompass: high-precision joint estimation algorithms for lithium battery State-of-Charge (SOC) and State-of-Health (SOH); plug-and-play communication protocol adaptation modules for heterogeneous multi-source energy equipment; and an edge-side lightweight EMS platform. The company holds six authorized invention patents, 19 utility model patents, and 14 software copyrights. It has passed third-party testing by China Electric Power Research Institute (CEPRI) (Test Report No.: CEPRI-TEST-2024-EN0883).  

The company holds the following qualifications: Grade III General Contracting Qualification for Electric Power Engineering Construction; License for Installation (Maintenance/Testing) of Electric Power Facilities (Grade IV for Installation, Grade IV for Testing); and ISO 9001/14001/45001 integrated management system certifications. It has established the Liaoning Provincial Enterprise Technology Center (certified under Document No. Liao Xin Gong Fa [2022] 187 issued by the Liaoning Provincial Department of Industry and Information Technology).  

Representative projects include: (1) the comprehensive energy retrofit project for Dalian Ice Mountain Group in 2023—featuring combined cooling, heating, and power (CCHP) plus energy storage—with a total investment of RMB 120 million and annual peak-shaving and valley-filling electricity volume of 18.6 GWh; and (2) the 12 MW / 24 MWh user-side energy storage peak-shaving project at Hengli Petrochemical Park, selected in 2024 for the demonstration project list issued by the Liaoning Provincial Energy Administration.  

Public records indicate no foreign direct investment, international engineering contracting experience, or overseas subsidiaries. Its current business operations are confined to China’s Bohai Rim Economic Circle. Cooperative models include EPC general contracting, technology licensing plus engineering implementation, customized development of intelligent energy platforms, and full-lifecycle operation & maintenance (O&M) outsourcing.

DaLianXiangFeng Petrochemical Equipment co.ltd, located in Ganjingzi District, Dalian City, Liaoning Province, is a national high-tech enterprise specializing in the research and development, design, manufacturing, and technical services of special pressure vessels and complete equipment for the petroleum, chemical, and energy sectors. It falls under the specialized equipment manufacturing industry (C35), with a focus on refining & petrochemical equipment and advanced process equipment. The company’s registered capital and paid-in capital are both RMB 50 million. Its registration status is “active,” and it is currently undergoing a critical transition from a regional equipment manufacturer to a professionalized, standardized, and branded service provider.  

The company’s core business involves hydrogenation reactors’ key components and associated skid-mounted systems, serving typical applications such as coal chemical processing, refinery hydroprocessing, natural gas purification, coal-to-oil conversion, and environmentally friendly supercritical water oxidation. Its customer base includes major energy groups and their engineering companies—e.g., Sinopec, CNPC, CNOOC, State Energy Group, Hengli Petrochemical, and Rongsheng Petrochemical.  

Core capabilities include dual-standard design of stationary pressure vessels per ASME Section VIII Division 1 and GB/T 150; manufacturing of Class A1 high-pressure vessels and Class A2 Category III low- and medium-pressure vessels; proprietary technologies such as structural optimization of ultra-high-pressure hydrogen storage and transport vessels, welding of duplex stainless steel resistant to hydrogen sulfide corrosion, and integrated modular skid-mounted reactor systems. The company holds five invention patents and 23 utility model patents. Critical welds undergo 100% radiographic testing (RT) plus phased-array ultrasonic testing (PAUT), meeting NDE Level II or higher requirements.  

Certifications held include: National High-Tech Enterprise Certificate (GR202121000283, re-examined and approved in 2024); Special Equipment Production License (TS2221028-2027); and ISO 9001/14001/45001 integrated management system certifications. All qualifications are verifiable on official platforms.  

Representative projects delivered include: a three-stage separator (15.0 MPa) for CNPC Southwest Oil & Gasfield’s Longwangmiao Gas Purification Plant (H₂S content ≥12%); internal component assemblies for four vacuum gas oil hydrotreating reactors in Hengli Petrochemical’s Dalian Refining & Chemical Integration Project; and localization of high-pressure reactors for the supercritical water oxidation unit at State Energy Group’s Ordos Coal-to-Oil Branch.  

Over the past three years, the company exported pressure vessel components to Kazakhstan and Uzbekistan via general trade terms in 12 batches, totaling approximately USD 2.86 million. Public records do not indicate that the company has obtained the ASME “U” stamp, PED certification, or established overseas entities. Its international business remains primarily export-oriented, supporting technical solution alignment, supply of core equipment, and collaborative localization implementation.

Dalian Zion Technology Co.,Ltd. is registered in the Songmu Island Chemical Industry Park, Puwan New Area, Dalian City, Liaoning Province. It is a technology service enterprise specializing in industrial information security and a national high-tech enterprise currently in the stage of large-scale application and deep industry expansion. The company’s core business covers security testing of industrial control systems (ICS) for critical infrastructure in the chemical industry, firmware security analysis of embedded devices, in-depth parsing of industrial protocols and modeling of anomalous behaviors, and provision of customized security protection solutions for coal chemical, petrochemical, fine chemical, and environmental protection enterprises. Its clients include State Grid Liaoning Electric Power Co., Ltd., China Huaneng Group Northeast Branch, and Dalian Shipbuilding Industry Group Co., Ltd.—major energy and heavy-industry customers. Its core capabilities are embodied in its proprietary “SiAn-FirmwareScan” firmware static analysis platform and “ICS-DeepSight” dynamic behavior simulation sandbox, which support source-code-free reverse engineering and zero-day vulnerability identification for Siemens S7-1200/1500, Rockwell ControlLogix, and Schneider Modicon series PLC firmware, and achieve deep compatibility with domestic hardware such as LoongArch-based Loongson 3A5000 and Phytium D2000, as well as domestic operating systems including Huawei EulerOS and UnionTech UOS. The company has obtained dual certifications for ISO 9001:2015 Quality Management Systems and ISO/IEC 27001:2022 Information Security Management Systems; holds the “Commercial Cryptography Product Certification Certificate” (GM005220240008); is listed in the “Recommended Directory of Cybersecurity Level Protection Assessment Institutions” (DLP-2025-LN-037); and has been designated by the National Industrial Information Security Development Research Center as an “Industrial Information Security Emergency Service Support Unit.” Representative achievements include: serving continuously from 2022 to 2024 as the contractor responsible for industrial control asset mapping and risk assessment tasks at the Liaoning Provincial Node of the National Industrial Information Security Monitoring and Early-Warning Network; delivering full-lifecycle security hardening services for the Train Control and Management System (TCMS) of CRRC Dalian Locomotive & Rolling Stock Co., Ltd., with results selected for inclusion in the Ministry of Industry and Information Technology’s “2023 Typical Cases of Data Security Management Pilots in the Industrial Sector”; and completing, in 2024, the protocol stack compatibility security audit of the Russian SCADA platform within the China-Russia cross-border energy pipeline automation system joint defense project, resulting in the bilingual (Chinese-Russian) “White Paper on Interoperability Security for Cross-Border Industrial Control Systems.” Leveraging the China–Northeast Asia Cybersecurity Cooperation Mechanism, the company has established a technical response liaison point in Astana, Kazakhstan, providing localized industrial control security assessment services to the five Central Asian countries, primarily through collaborative technical validation, joint standard research, and emergency support—publicly available information does not indicate direct export sales or establishment of overseas subsidiaries.

Dalian Musashi New Materials Co., Ltd. is a high-tech enterprise established in China by Japan’s Musashi Group, specializing in the research, development, production, and sales of high-performance metal surface treatment materials. The company positions itself as a key process-support service provider for sectors including automotive components, rail transit equipment, structural components for new-energy power battery systems, and high-end manufacturing equipment. Its core products include cyanide-free alkaline zinc alloy electroplating additives, low-phosphorus/phosphate-free ceramic conversion coatings, water-based sealers, and specialty passivators—environmentally friendly pre-treatment and functional coating materials. Its flagship product, the “MZ-8000 Series Cyanide-Free Zinc Plating Brighteners,” has been certified by Liaoning Province as a pioneering industrial product (first-of-its-kind) for critical components. Relying on its provincial-level enterprise technology center, the company holds seven invention patents—including two PCT international patents—and 15 utility model patents. Its technological focus centers on reducing heavy-metal usage, minimizing wastewater discharge, and adapting processes to low-temperature energy-saving operations, fully complying with GB/T 39213–2020, EU RoHS, and REACH regulations. The company has obtained ISO 9001:2015 Quality Management System certification, ISO 14001:2015 Environmental Management System certification, and Level-3 Standardization Certification for Work Safety. It has also participated in the revision of industry standard JB/T 13785–2020. Its customer base includes leading enterprises such as FAW Jiefang, CRRC Dalian, BYD Battery Dalian Base, and Lingyun Co., Ltd. Its business operations span Northeast, North, and East China. The company provides upstream and downstream industrial chain partners with customized material solutions, process compatibility support, and collaborative technical development services, and is a formal member of the Electroplating Branch of the China Nonferrous Metals Industry Association.

Dalian Wonful Pharmaceutical Co,Ltd., established in 2003 and located in the Jinpu New Area of Dalian City, Liaoning Province, is a national high-tech enterprise specializing in the research, development, manufacturing, and sales of active pharmaceutical ingredients (APIs) and finished pharmaceutical products (FPPs). The company is currently in a stable, scaled-up development phase. All its production lines have obtained Good Manufacturing Practice (GMP) certification from China’s National Medical Products Administration (NMPA). Publicly available information does not indicate that the company holds chemical engineering design qualifications or EPC general contracting capabilities.  

The company’s core business covers large-scale production of specialty APIs—including metformin hydrochloride, acarbose, and glimepiride—as well as compliant manufacturing of oral solid dosage forms such as tablets, capsules, and granules. It primarily serves domestic listed pharmaceutical enterprises’ CDMO needs and supports generic drug consistency evaluations. The company has established stable delivery capabilities in the fields of fine chemicals and pharmaceutical intermediates.  

Its core competencies include: development of highly stable sustained-release formulation processes (e.g., “A Highly Stable Metformin Hydrochloride Sustained-Release Tablet and Its Preparation Method,” awarded the Second Prize of the 2024 Liaoning Provincial Science and Technology Progress Award); API impurity profiling technology (participated in drafting the group standard T/CNPPA 3015-2024); international registration and quality system implementation capabilities supported by EU Certification of a Suitability of the Active Substance for Use in Human Medicinal Products (CEP, certificate number: CEP 2022-489-A) and U.S. FDA Drug Master File (DMF) registration (DMF#0356721); and end-to-end quality control and regulatory compliance assurance enabling stable supply to regulated markets in Europe and the United States.  

The company holds a “Pharmaceutical Production License” (Liaoning No. 20160008), maintains ISO 9001 Quality Management System certification, and completed integrated certification for ISO 14001 (Environmental Management) and ISO 45001 (Occupational Health and Safety Management) in 2021. It owns 12 valid invention patents and 8 utility model patents, and operates a provincial-level enterprise technology center accredited by Liaoning Province.  

Representative achievements include providing customized API CDMO services to China Resources Double-Crane Pharmaceutical Co., Ltd., Huadong Medicine Co., Ltd., and CSPC Pharmaceutical Group Co., Ltd. In 2024, its export volume of metformin hydrochloride reached 286 metric tons, accounting for approximately 11.3% of China’s total exports of the same product. Its independently developed “Acarbose Mini-Tablet Capsule” received marketing authorization in 2023 (National Drug Approval Number: H20233821). Its products have entered 21 countries and regions—including Thailand, Vietnam, Saudi Arabia, the United Arab Emirates, Brazil, and Mexico—and overseas revenue accounted for 34.6% of total revenue in 2025. The company possesses cross-border delivery capabilities aligned with ICH, USP, and EP standards, and supports collaboration models combining technology licensing with localized engineering implementation.

Dalian Tongkang New Materials Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and application of high-performance thermoplastic composites, positioned to engineer and industrialize advanced lightweight materials. The company’s core business encompasses technological development, manufacturing, and sales of thermoplastic composite products reinforced with carbon fiber or glass fiber—such as polyphenylene sulfide (PPS), polyether ether ketone (PEEK), and polyamide 66 (PA66). Its products are widely applied in high-end equipment sectors, including structural components for new-energy vehicle battery packs, interior and undercarriage parts for rail transit systems. The enterprise possesses independent capability to produce continuous-fiber thermoplastic prepregs; its core technologies focus on optimizing compression molding processes, controlling fiber orientation, and manufacturing low-warping panels. It has developed representative products such as high-temperature-resistant (≥220°C) carbon-fiber-reinforced PPS profiles and flame-retardant glass-fiber-reinforced PA66 structural components, and has achieved stable small-batch supply to domestic electric bus and high-speed rail manufacturers. The company holds three authorized invention patents and eleven utility model patents. Its technological achievements support the Liaoning Provincial Key R&D Program project titled “Application Demonstration of Lightweight Thermoplastic Composites in Commercial Vehicle Undercarriage Components,” for which it undertakes material-process compatibility adaptation and prototype component fabrication tasks, successfully passing mid-term evaluation. In terms of qualifications, the company has obtained ISO 9001:2015 Quality Management System Certification and Weapons Equipment Quality Management System Certification (Certificate No.: 19GJ12345), demonstrating its capacity to supply the defense industry; it is also a corporate member of the Chinese Society for Composite Materials. Currently, the company primarily serves key manufacturing customers in Northeast China and other major domestic regions, offering collaboration models including customized material development, joint process problem-solving, prototype fabrication, and small-batch supply—committed to delivering reliable, verifiable thermoplastic composite solutions for lightweight transportation equipment.

Dalian Tianlai Security Risk Management Technology Co., Ltd. is located in the Dalian High-Tech Industrial Development Zone, Liaoning Province. It is a technology service provider specializing in enterprise-level intelligent security risk identification, quantitative risk assessment, and compliance governance. The company operates within the information security technology services industry and is currently in the stage of large-scale application and promotion. Its core business targets security risk governance needs in coal chemical, petrochemical, fine chemical, and new materials sectors within the chemical industry, offering services including security risk data modeling, dynamic monitoring platform development, SaaS-based risk assessment, and resilience assessment support for supply chain disruption scenarios. Its “TL-RiskMaster” solution integrates rule engines, dynamic Bayesian networks, and lightweight knowledge graphs, supporting dual-track compatibility with GB/T 31821–2015 and ISO 31000:2018. The company has built a structured knowledge graph covering 17 types of equipment and 327 risk factors, and has deployed regional-level risk monitoring nodes in six national-level industrial parks, including the Dalian Pilot Free Trade Zone and the Shenyang China-Germany Equipment Manufacturing Park. The company holds three invention patents and 37 software copyrights. Its “Tianlai Enterprise Security Risk Intelligent Assessment Platform V4.2” has passed the compatibility verification for China’s Level-3 Cybersecurity Protection Standard conducted by the China Information Security Evaluation Center and has been selected as a pilot demonstration project under the Ministry of Industry and Information Technology’s 2024 Cybersecurity Technology Application Program. The company has obtained dual certifications for ISO 9001:2015 Quality Management Systems and ISO/IEC 27001:2022 Information Security Management Systems; it also holds a Grade-B qualification for confidential information system integration (risk assessment category) issued by the State Secrecy Bureau and a CMMI Level 3 appraisal certificate. Representative projects include continuously undertaking the People’s Bank of China Dalian Central Sub-Branch’s “Regional Operational Risk Stress Testing Support Project for Small and Medium-Sized Financial Institutions,” providing customized risk indicator databases and scenario simulation engines to 23 city commercial banks and rural credit cooperatives in Liaoning Province; and completing in 2023 the State Grid Liaoning Electric Power Co., Ltd.’s “Construction Project for Full-Life-Cycle Safety Risk Mapping of Transmission and Transformation Assets,” whose outcomes were incorporated into the “State Grid Corporation Digital Risk Control White Paper (2024).” Internationally, the company does not maintain overseas branches but has licensed its risk assessment algorithm modules to Singapore-based FinGuard Pte. Ltd. (Contract Registration No.: Liao Ke Mao Xu [2024] No. 089). Additionally, as the Chinese representative, it participates in the China-Japan-Korea “East Asia Resilience Framework (EARF)” Technical Working Group, providing methodological support for risk transmission modeling. Public records do not indicate direct involvement by the company in EPC general contracting, process package development, or integrated equipment manufacturing for chemical industry projects.

BBChem Co.,Ltd., located in Ganjingzi District, Dalian City, Liaoning Province, is a national high-tech enterprise specializing in the research, development, production, and sales of pharmaceutical intermediates, fine chemicals, and novel boron-containing compounds. The company operates within the chemical raw materials and chemical products manufacturing industry (C26). It was first certified as a national high-tech enterprise in 2018 and successfully passed re-examinations in 2021 and 2024. As of the end of 2025, its total assets amounted to RMB 327 million, with 216 employees, of whom 38.9% are engaged in R&D.  

The company’s core businesses focus on four major areas: key intermediates for anti-tumor drugs; boron-containing targeted therapeutic reagents; electronic-grade specialty boronic acid derivatives; and ¹⁸F-labeled precursor reagents for nuclear medicine. Its clients include leading domestic pharmaceutical enterprises such as Hengrui Medicine and CSPC Zhongnuo, as well as international material industry giants including Sumitomo Chemical, Toray Industries, Inc., and Tosoh Corporation.  

The company possesses end-to-end R&D capabilities spanning from milligram-scale molecular design to hundred-kilogram-scale process validation. It has established the Liaoning Provincial Engineering Technology Research Center for Boron Chemistry and is equipped with a GMP Class 10,000 clean synthesis laboratory and a pilot-scale platform. It holds seven invention patents (including two PCT international patents) and twelve utility model patents. Its “low-temperature catalytic boron esterification process” achieves a target product yield of 92.3% and a total impurity level of ≤0.15%; related technologies have been incorporated into the 2025 edition of the Chinese Pharmacopoeia. The company has obtained certifications for ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, holds a “Safety Production License for Hazardous Chemicals,” and has completed SIS+DCS automated control upgrades across all production facilities, which have passed provincial-level acceptance.  

The company participates in a sub-project under the National Key R&D Program “Strategic Advanced Electronic Materials” and is among the first domestic enterprises to supply key intermediates for bortezomib series drugs. Its nuclear medicine product “4-[¹⁸F]fluorophenylboronic acid” has passed industry technical appraisal and is stably supplied to 12 PET centers, including Peking Union Medical College Hospital and Shanghai Proton and Heavy Ion Hospital.  

Exports cover 17 countries, including Japan, South Korea, Germany, the United States, and India. In 2025, export revenue totaled USD 42.8 million, with exports to Japan and South Korea accounting for 53.7%. In 2024, the company signed a technology licensing agreement with Germany’s BorTech GmbH, authorizing the latter to manufacture and sell the patented compound “sodium dicyclopentadienylborate” in Europe—the first commercial case in China’s boron chemistry field involving the export of core synthetic processes to a developed country. The company offers technology licensing plus engineering implementation, consortium-based collaboration, and customized products and process packages compliant with multiple standards, including SEMI F57-0312, USP/EP, and GB/T 39371–2020.